White label ELPA - ClinicalTrials.eu

Study Comparing BP11 and Omalizumab for Patients with Chronic Spontaneous Urticaria Resistant to H1 Antihistamines

Not recruiting

3 1 1
Investigated Diseases:
- Chronic spontaneous urticaria
Investigated Drugs:
- Omalizumab
Study on Rituximab for Adults with Schizophrenia Spectrum Disorder

Not recruiting

2 1 1 1
Investigated Diseases:
- Schizophrenia
Investigated Drugs:
- Rituximab
Study on LAVA-1207 and Pembrolizumab for Patients with Advanced Prostate Cancer Resistant to Treatment

Not recruiting

1 1 1 1
Investigated Drugs:
- Humanised Bispecific Immunoglobulin Vhh Fragments Against Psma And Vgamma9Vdelta2 T-Cell Receptor
- Pembrolizumab
Study on Batoclimab for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Not recruiting

2 1
Investigated Diseases:
- Chronic inflammatory demyelinating polyradiculoneuropathy
Investigated Drugs:
- Batoclimab
+8
Study of Sitravatinib and Nivolumab vs. Docetaxel for Patients with Advanced Non-Small Cell Lung Cancer After Chemotherapy and Checkpoint Inhibitor Therapy

Not recruiting

3 1 1 1
Investigated Drugs:
Study on the Effectiveness of Botulinum Toxin Type A for Patients with Cervical Dystonia and Abnormal Muscle Activity

Not recruiting

3 1 1
Investigated Diseases:
- Torticollis
Investigated Drugs:
Study on Anifrolumab for Adults with Chronic or Subacute Cutaneous Lupus Erythematosus Unresponsive to Antimalarial Therapy

Not recruiting

3 1
Investigated Drugs:
- Anifrolumab
+7
Study of Sotatercept for Patients with Severe Pulmonary Arterial Hypertension at High Risk of Mortality

Not recruiting

3 1
Investigated Diseases:
- Pulmonary arterial hypertension
Investigated Drugs:
- Sotatercept
Study of petosemtamab compared to standard therapy in previously treated patients with metastatic or recurrent head and neck cancer

Not recruiting

3 1 1 1
Investigated Drugs:
+6
Study on Darolutamide and Capecitabine for Patients with Advanced Triple-Negative Androgen Receptor Positive Breast Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Triple negative breast cancer
Investigated Drugs:
- Capecitabine
- Darolutamide

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies